Pharma & MedTech Business Intelligence is Education and Training Services (B2B) in United States that focus on Provider business. They cover business area such as Provider, news, information, insight, analysis, healthcare, publication, conference, database, report, pharmaceutical and medical device professional.
Education and Training Services (B2B)
-
Provider
-
52 Vanderbilt Avenue
11th Floor
New York, NY 10017
United States
Private
Providernewsinformationinsightanalysishealthcarepublicationconferencedatabasereportpharmaceutical and medical device professional
* We use standard office opening hours in near Pharma & MedTech Business Intelligence's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Pharma & MedTech Business Intelligence is Education and Training Services (B2B) business from United States that founded in - ( years old in ), Pharma & MedTech Business Intelligence business is focusing on Provider.
Pharma & MedTech Business Intelligence headquarter office and corporate office address is located in 52 Vanderbilt Avenue 11th Floor New York, NY 10017 United States.
Pharma & MedTech Business Intelligence was founded in United States.
In , Pharma & MedTech Business Intelligence is currently focus on Provider sector.
Above is snippet of Google Trends for "Provider" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Pharma & MedTech Business Intelligence, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.